Metallothioneins (MTs) are small cysteine-rich intracellular proteins. The best-known biological functions of MTs are sequestration of metal ions and maintenance of redox homeostasis. Despite these protective functions, it has been demonstrated that MTs are involved in tumorigenesis, cellular differentiation, drug resistance, and metabolic disorders such as diabetes and obesity, in which MTs expression is substantially deregulated in adipose tissue. In addition, many studies have experimentally evidenced a possible role of MTs in the development of diabetes. Given the rich biochemical properties of MTs, it can be concluded that they are involved in several aspects of development and progression of obesity and diabetes. Thus, evaluation of expression of MTs could serve as biomarker to personalize available therapeutic interventions and possibly to develop novel advanced therapeutic modalities. Overall, the purpose of this review is analyze and review the latest studies aimed on the multiple roles of MTs in metabolic disorders, possible use of MTs as obesity and diabetes biomarkers and the role of MTs in cardioprotection during diabetes progression.

Department of Chemistry and Biochemistry Mendel University in Brno Brno Czech Republic

Therapeutic Innovation Research Center Federal University of Pernambuco Recife PE Brazil

Zobrazit více v PubMed

Kawakami T, Takasaki S, Kadota Y, Fukuoka D, Sato M, Suzuki S. Regulatory role of metallothionein-1/2 on development of sex differences in a high-fat diet-induced obesity. Life Sci. 2019;226:12–21. PubMed DOI

Hernandez-Garcia J, Navas-Carrillo D, Orenes-Pinero E. Alterations of circadian rhythms and their impact on obesity, metabolic syndrome and cardiovascular diseases. Crit Rev Food Sci Nutr. 2020;60:1038–47. PubMed DOI

Almendros I, Martinez-Garcia MA, Farre R, Gozal D. Obesity, sleep apnea, and cancer. Int J Obes. 2020;44:1653–67. PubMed

Lindeque JZ, van Rensburg PJJ, Louw R, van der Westhuizen FH, Florit S, Ramírez L, et al. Obesity and metabolomics: metallothioneins protect against high-fat diet-induced consequences in metallothionein knockout mice. OMICS J Integr Biol. 2015;19:92–103. PubMed DOI

Fuster JJ, Ouchi N, Gokce N, Walsh K. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. CircRes. 2016;118:1786–807. PubMed PMC

Sato M, Kawakami T, Kadota Y, Mori M, Suzuki S. Obesity and metallothionein. Curr Pharm Biotechnol. 2013;14:432–40. PubMed DOI

Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9:367–77. PubMed DOI PMC

Chueire VB, Muscelli E. Effect of free fatty acids on insulin secretion, insulin sensitivity and incretin effect - a narrative review. Arch Endocrinol Metab. 2021;65:24–31. PubMed PMC

Edgerton DS, Kraft G, Smith M, Farmer B, Williams PE, Coate KC, et al. Insulin’s direct hepatic effect explains the inhibition of glucose production caused by insulin secretion. JCI Insight. 2017;2:91863. PubMed DOI PMC

Margoshes M, Vallee BL. A cadmium protein from equine kidney cortex. J Am Chem Soc. 1957;79:4813–4. DOI

Morrell A, Tallino S, Yu L, Burkhead JL. The role of insufficient copper in lipid synthesis and fatty-liver disease. Iubmb Life. 2017;69:263–70. PubMed DOI PMC

Carpene E, Andream G, Isam G. Metallothionein functions and structural characteristics. J Trace Elem Med Biol. 2007;21:35–9. PubMed DOI

Mulder TPJ, Janssens AR, Verspaget HW, Lamers C. Plasma metallothionein concentration in patients with liver disorders - special emphasis on the relation with primary bliliary cirrhosis. Hepatology. 1991;14:1008–12. PubMed DOI

Kiapidou S, Liava C, Kalogirou M, Akriviadis E, Sinakos E. Chronic kidney disease in patients with non-alcoholic fatty liver disease: what the Hepatologist should know?. Ann Hepatol. 2020;19:134–44. PubMed DOI

Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908–22. PubMed DOI PMC

Kadota Y, Toriuchi Y, Aki Y, Mizuno Y, Kawakami T, Nakaya T, et al. Metallothioneins regulate the adipogenic differentiation of 3T3-L1 cells via the insulin signaling pathway. PLoS One. 2017;12:1–18. PubMed DOI PMC

Cong WT, Ma WD, Zhao T, Zhu ZX, Wang YH, Tan Y, et al. Metallothionein prevents diabetes-induced cardiac pathological changes, likely via the inhibition of succinyl-CoA:3-ketoacid coenzyme A transferase-1 nitration at Trp(374). Am J Physiol Endocrinol Metab. 2013;304:826–35. PubMed DOI

Do MS, Nam SY, Hong SE, Kim KW, Duncan JS, Beattie JH, et al. Metallothionein gene expression in human adipose tissue from lean and obese subjects. Horm Metab Res. 2002;34:348–51. PubMed DOI

Gu JL, Cheng YL, Wu H, Kong LL, Wang SD, Xu Z, et al. Metallothionein is downstream of Nrf2 and partially mediates sulforaphane prevention of diabetic cardiomyopathy. Diabetes. 2017;66:529–42. PubMed DOI PMC

Gu JL, Yan XQ, Dai XZ, Wang YH, Lin Q, Xiao J, et al. Metallothionein preserves Akt2 activity and cardiac function via inhibiting TRB3 in diabetic hearts. Diabetes. 2020;69:267. PubMed DOI PMC

Cai L. Metallothionein as an adaptive protein prevents diabetes and its toxicity. Nonlinearity Biol Toxicol Med. 2004;2:89–103. PubMed DOI PMC

Szrok S, Stelmanska E, Turyn J, Bielicka-Gieldon A, Sledzinski T, Swierczynski J. Metallothioneins 1 and 2, but not 3, are regulated by nutritional status in rat white adipose tissue. Genes Nutr. 2016;11:18. PubMed DOI PMC

Liu Q, Wang S, Cai L. Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage. J Diab Investig. 2014;5:623–34. PubMed DOI PMC

Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E, Di Rosa G, et al. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci. 2015;16:378–400. PubMed DOI PMC

Manna P, Jain SK. Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies. Metab Syndr Relat Disord. 2015;13:423–44. PubMed DOI PMC

Isani G, Carpene E. Metallothioneins, unconventional proteins from unconventional animals: a long journey from nematodes to mammals. Biomolecules. 2014;4:435–57. PubMed DOI PMC

Merlos Rodrigo MA, Krejcova L, Kudr J, Cernei N, Kopel P, Richtera L, et al. Fully automated two-step assay for detection of metallothionein through magnetic isolation using functionalized γ-Fe2O3 particles. J Chrom B. 2016;1039:17–27. PubMed DOI

Miles AT, Hawksworth GM, Beattie JH, Rodilla V. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit Rev Biochem Mol Biol. 2000;35:35–70. PubMed DOI

Juarez-Rebollar D, Rios C, Nava-Ruiz C, Mendez-Armenta M. Metallothionein in brain disorders. Oxid Med Cell Longev. 2017;2017:1–12. PubMed DOI PMC

Si M, Lang J. The roles of metallothioneins in carcinogenesis. J Hematol Oncol. 2018;11:1–20. PubMed DOI PMC

Thirumoorthy N, Shyam Sunder A, Manisenthil Kumar KT, Senthil kumar M, Ganesh GNK, Chatterjee M. A review of metallothionein isoforms and their role in pathophysiology. World J Surg Oncol. 2011;9:1–7. PubMed DOI PMC

Takahashi S. Positive and negative regulators of the metallothionein gene (Review). Mol Med Rep. 2015;12:795–9. PubMed DOI

Dong G, Chen H, Qi M, Dou Y, Wang Q. Balance between metallothionein and metal response element binding transcription factor 1 is mediated by zinc ions (review). Mol Med Rep. 2015;11:1582–6. PubMed DOI

Andrews GK. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharm. 2000;59:95–104. PubMed DOI

Kimura T, Kambe T. The functions of metallothionein and ZIP and ZnT transporters: an overview and perspective. Int J Mol Sci. 2016;17:1–22. PubMed DOI PMC

Laity JH, Andrews GK. Understanding the mechanisms of zinc-sensing by metal-response element binding transcription factor-1 (MTF-1). Arch Biochem Biophys. 2007;463:201–10. PubMed DOI

Guo L, Lichten LA, Ryu MS, Liuzzi JP, Wang F, Cousins RJ. STAT5-glucocorticoid receptor interaction and MTF-1 regulate the expression of ZnT2 (Slc30a2) in pancreatic acinar cells. Proc Natl Acad Sci USA. 2010;107:2818–23. PubMed DOI PMC

Lichten LA, Ryu MS, Guo L, Embury J, Cousins RJ. MTF-1-mediated repression of the zinc transporter Zip10 is alleviated by zinc restriction. PLoS One. 2011;6:1–12. PubMed DOI PMC

Fukada T, Kambe T. Molecular and genetic features of zinc transporters in physiology and pathogenesis. Metallomics. 2011;3:662–74. PubMed DOI

Kambe T, Tsuji T, Hashimoto A, Itsumura N. The physiological, biochemical, and molecular roles of zinc transporters in zinc homeostasis and metabolism. Physiol Rev. 2015;95:749–84. PubMed DOI

Chimienti F, Devergnas S, Pattou F, Schuit F, Garcia-Cuenca R, Vandewalle B, et al. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J Cell Sci. 2006;119:4199–206. PubMed DOI

Chimienti F, Devergnas S, Favier A, Seve M. Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes. 2004;53:2330–7. PubMed DOI

Huang Q, Du J, Merriman C, Gong Z. Genetic, functional, and immunological study of ZnT8 in diabetes. Int J Endocrinol. 2019;2019:1–11. PubMed PMC

Golay A, Bobbioni E. The role of dietary fat in obesity. Int J Obes. 1997;21:2–11. PubMed

Rinella ME, Sookoian S. From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease. J Lipid Res. 2024;65:100485. PubMed DOI PMC

Liu SS, Yuan JT, Yue WH, Bi YW, Shen XY, Gao JL, et al. GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice. Biochim Biophys Acta Mol Basis Dis. 2018;1864:3257–67. PubMed DOI

Grasselli E, Voci A, Demori I, De Matteis R, Compalati AD, Gallo G, et al. Effects of binge ethanol on lipid homeostasis and oxidative stress in a rat model of nonalcoholic fatty liver disease. J Physiol Biochem. 2014;70:341–53. PubMed

Martínez-Chantar ML, Avila MA, Lu SC. Hepatocellular carcinoma: updates in pathogenesis, detection and treatment. Cancers. 2020;12:2729. PubMed PMC

Tao X, Zheng J-M, Xu A-M, Chen X-F, Zhang S-H. Downregulated expression of metallothionein and its clinicopathological significance in hepatocellular carcinoma. Hepatol Res. 2007;37:820–7. PubMed DOI

Merlos Rodrigo MA, Jimenez Jimemez AM, Haddad Y, Bodoor K, Adam P, Krizkova S, et al. Metallothionein isoforms as double agents - their roles in carcinogenesis, cancer progression and chemoresistance. Drug Resist Updat. 2020:52:100691. PubMed

Hurt RT, Kulisek C, Buchanan LA, McClave SA. The obesity epidemic: challenges, health initiatives, and implications for gastroenterologists. Gastroenterol Hepatol. 2010;6:780–92. PubMed PMC

Akil L, Ahmad HA. Relationships between obesity and cardiovascular diseases in four southern states and Colorado. J Health Care Poor Underserved. 2011;22:61–72. PubMed DOI PMC

Setayesh T, Nersesyan A, Misik M, Ferk F, Langie S, Andrade VM, et al. Impact of obesity and overweight on DNA stability: Few facts and many hypotheses. Mutat Res Rev Mutat Res. 2018;777:64–91. PubMed DOI

Davegardh C, Broholm C, Perfilyev A, Henriksen T, Garcia-Calzon S, Peijs L, et al. Abnormal epigenetic changes during differentiation of human skeletal muscle stem cells from obese subjects. BMC Med. 2017;15:1–27. PubMed DOI PMC

Snyder EE, Walts B, Pérusse L, Chagnon YC, Weisnagel SJ, Rankinen T, et al. The Human Obesity Gene Map: The 2003 Update. Obes Res. 2004;12:369–439. PubMed DOI

Wang B, Wood IS, Trayhurn P. PCR arrays identify metallothionein-3 as a highly hypoxia-inducible gene in human adipocytes. Biochem Biophys Res Commun. 2008;368:88–93. PubMed DOI PMC

Han CY. Roles of reactive oxygen species on insulin resistance in adipose tissue. Diab Metab J. 2016;40:272–9. PubMed DOI PMC

Castro JP, Grune T, Speckmann B. The two faces of reactive oxygen species (ROS) in adipocyte function and dysfunction. Biol Chem. 2016;397:709–24. PubMed DOI

Jankovic A, Korac A, Buzadzic B, Otasevic V, Stancic A, Daiber A, et al. Redox implications in adipose tissue (dys)function—A new look at old acquaintances. Redox Biol. 2015;6:19–32. PubMed DOI PMC

Wlodarczyk M, Nowicka G. Obesity, DNA damage, and development of obesity-related diseases. Int J Mol Sci. 2019;20:1–18. PubMed DOI PMC

O’Brien A, Kedia-Mehta N, Tobin L, Veerapen N, Besra GS, O’Shea D, et al. Targeting mitochondrial dysfunction in MAIT cells limits IL-17 production in obesity. Cell Mol Immunol. 2020;17:1193–5. PubMed DOI PMC

Baldini F, Fabbri R, Eberhagen C, Voci A, Portincasa P, Zischka H, et al. Adipocyte hypertrophy parallels alterations of mitochondrial status in a cell model for adipose tissue dysfunction in obesity. Life Sci. 2021;265:1–9. PubMed DOI

Li Y, Lee SH, Piao M, Kim HS, Lee KY. Metallothionein 3 inhibits 3T3-L1 adipocyte differentiation via reduction of reactive oxygen species. Antioxidants. 2023;12:640. PubMed DOI PMC

Nakatani Y, Kaneto H, Kawamori D, Yoshiuchi K, Hatazaki M, Matsuoka T, et al. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J Biol Chem. 2005;280:847–51. PubMed DOI

Ellis CD, Wang FD, MacDiarmid CW, Clark S, Lyons T, Eide DJ. Zinc and the Msc2 zinc transporter protein are required for endoplasmic reticulum function. J Cell Biol. 2004;166:325–35. PubMed DOI PMC

Miura N, Koizumi S. Gene expression profiles in the liver and kidney of metallothionein-null mice. Biochem Biophys Res Commun. 2005;332:949–55. PubMed DOI

Hambidge M. Human zinc deficiency. J Nutr. 2000;130:1344–9. PubMed DOI

Konukoglu D, Turhan MS, Ercan M, Serin O. Relationship between plasma leptin and zinc levels and the effect of insulin and oxidative stress on leptin levels in obese diabetic patients. J Nutr Biochem. 2004;15:757–60. PubMed DOI

Marreiro DD, Geloneze B, Tambascia MA, Lerario AC, Halpern A, Cozzolino SMF. Effect of zinc supplementation on serum leptin levels and insulin resistance of obese women. Biol Trace Elem Res. 2006;112:109–18. PubMed DOI

Morais JBS, Severo JS, Beserra JB, Soares De Oiveira AR, Cruz KJC, et al. Association between cortisol, insulin resistance and zinc in obesity: a mini-review. Biol Trace Elem Res. 2019;191:323–30. PubMed DOI

Fukunaka A, Fujitani Y. Role of zinc homeostasis in the pathogenesis of diabetes and obesity. Int J Mol Sci. 2018;19:1–14. PubMed DOI PMC

Fukunaka A, Fukada T, Bhin J, Suzuki L, Tsuzuki T, Takamine Y, et al. Zinc transporter ZIP13 suppresses beige adipocyte biogenesis and energy expenditure by regulating C/EBP-beta expression. PLoS Genet. 2017;13:1–23. PubMed DOI PMC

Zhang XQ, Zhang G, Zhang H, Karin M, Bai H, Cai DS. Hypothalamic IKK beta/NF-kappa B and ER stress link overnutrition to energy imbalance and obesity. Cell. 2008;135:61–73. PubMed DOI PMC

Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc. 2001;60:329–39. PubMed DOI

Habeebu SS, Liu J, Liu Y, Klaassen CD. Metallothionein-null mice are more susceptible than wild-type mice to chronic CdCl2-induced bone injury. Toxicol Sci. 2000;56:211–9. PubMed DOI

Kawakami T, Sugimoto H, Furuichi R, Kadota Y, Inoue M, Setsu K, et al. Cadmium reduces adipocyte size and expression levels of adiponectin and Peg1/Mest in adipose tissue. Toxicology. 2010;267:20–6. PubMed DOI

Beginheick N, Dalpescott M, Rowe J, Heick HMC. Zinc supplementation attenuates insulin secretory activity in pancreatic islets of the ob/ob mouse. Diabetes. 1985;34:179–84. PubMed DOI

Cousins RJ, Leinart AS. Tissue-specific regulation of zinc-metabolism and metallothionein genes by interleukin-1. FASEB J. 1988;2:2884–90. PubMed DOI

Rocha P, Amorim AD, de Sousa AF, do Monte SJH, Sousa L, Nogueira ND, et al. Expression of the zinc transporters genes and metallothionein in obese women. Biol Trace Elem Res. 2011;143:603–11. PubMed DOI

Wang SD, Gu JL, Xu Z, Zhang ZG, Bai T, Xu JX, et al. Zinc rescues obesity-induced cardiac hypertrophy via stimulating metallothionein to suppress oxidative stress-activated BCL10/CARD9/p38 MAPK pathway. J Cell Mol Med. 2017;21:1182–92. PubMed DOI PMC

Liang TT, Zhang Q, Sun WX, Xin Y, Zhang ZG, Tan Y, et al. Zinc treatment prevents type 1 diabetes-induced hepatic oxidative damage, endoplasmic reticulum stress, and cell death, and even prevents possible steatohepatitis in the OVE26 mouse model: Important role of metallothionein. Toxicol Lett. 2015;233:114–24. PubMed DOI

Kamigaki M, Sakaue S, Tsujino I, Ohira H, Ikeda D, Itoh N, et al. Oxidative stress provokes atherogenic changes in adipokine gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2006;339:624–32. PubMed DOI

Kawakami T, Nishiyama K, Kadota Y, Sato M, Inoue M, Suzuki S. Cadmium modulates adipocyte functions in metallothionein-null mice. Toxicol Appl Pharm. 2013;272:625–36. PubMed DOI

Gasser M, Lenglet S, Bararpour N, Sajic T, Wiskott K, Augsburger M, et al. Cadmium acute exposure induces metabolic and transcriptomic perturbations in human mature adipocytes. Toxicology. 2022;470:1–12. PubMed DOI

Young JL, Cave MC, Xu Q, Kong MY, Xu JX, Lin Q, et al. Whole life exposure to low dose cadmium alters diet-induced NAFLD. Toxicol Appl Pharm. 2022;436:1–24. PubMed DOI PMC

Liang YQ, Young JL, Kong MY, Tong YG, Qian Y, Freedman JH, et al. Gender differences in cardiac remodeling induced by a high-fat diet and lifelong, low-dose cadmium exposure. Chem. Res. Toxicol. 2019;32:1070–81. PubMed DOI PMC

Zhou WQ, Young JL, Men HB, Zhang HN, Yu HT, Lin Q, et al. Sex differences in the effects of whole-life, low-dose cadmium exposure on postweaning high-fat diet-induced cardiac pathogeneses. Sci Total Environ. 2022;809:1–14. PubMed DOI PMC

Jahng JW, Kim JG, Kim HJ, Kang DW, Lee JH. Chronic food restriction in young rats results in depression- and anxiety-like behaviors with decreased expression of serotonin reuptake transporter. Brain Res. 2007;1150:100–7. PubMed DOI

Kondoh M, Tsukahara R, Kuronaga M, Higashimoto M, Takiguchi M, Sato M. Enhancement of MT synthesis by leptin in fasted mice. Life Sci. 2002;71:2425–33. PubMed DOI

Olesen RH, Hyde TM, Kleinman JE, Smidt K, Rungby J, Larsen A. Obesity and age-related alterations in the gene expression of zinc-transporter proteins in the human brain. Transl Psychiatry. 2016;6:1–8. PubMed DOI PMC

Swindell WR. Metallothionein and the biology of aging. Ageing Res Rev. 2011;10:132–45. PubMed DOI PMC

Meunier N, O’Connor JM, Maiani G, Cashman KD, Secker DL, Ferry M, et al. Importance of zinc in the elderly: the ZENITH study. Eur J Clin Nutr. 2005;59:1–4. PubMed DOI

Takeda A. Zinc Signaling in the Hippocampus and its relation to pathogenesis of depression. Mol Neurobiol. 2011;44:166–74. PubMed DOI

Henstridge DC, Whitham M, Febbraio MA. Chaperoning to the metabolic party: the emerging therapeutic role of heat-shock proteins in obesity and type 2 diabetes. Mol Metab. 2014;3:781–93. PubMed DOI PMC

Habich C, Sell H. Heat shock proteins in obesity: links to cardiovascular disease. Horm Mol Biol Clin Investig. 2015;21:117–24. PubMed DOI

Kaur P, Reis MD, Couchman GR, Forjuoh SN, Greene JF, Asea A. Role of heat shock proteins in obesity and type 2 diabetes. In: Asea AAA, Pedersen BK, editors. Heat shock proteins and whole body physiology. Heat Shock Proteins, Springer, Dordrecht; 52010. p. 19–29. 10.1007/978-90-481-3381-9_2.

Mardan-Nik M, Pasdar A, Jamialahmadi K, Avan A, Mohebati M, Esmaily H, et al. Association of heat shock protein70-2 (HSP70-2) gene polymorphism with obesity. Ann Hum Biol. 2016;43:542–6. PubMed DOI

Sabbah NA, Rezk NA, Saad MSS. Relationship between heat shock protein expression and obesity with and without metabolic syndrome. Genet Test Mol Biomark. 2019;23:737–43. PubMed DOI

Kim S, Sohn I, Ahn J-I, Lee K-H, Lee YS, Lee YS. Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene. 2004;340:99–109. PubMed DOI

Timofeev YS, Kiselev AR, Dzhioeva ON, Drapkina OM. Heat shock proteins (HSPs) and cardiovascular complications of obesity: searching for potential biomarkers. Curr Issues Mol Biol. 2023;45:9378–89. PubMed DOI PMC

Tiss A, Khadir A, Abubaker J, Abu-Farha M, Al-Khairi I, Cherian P, et al. Immunohistochemical profiling of the heat shock response in obese non-diabetic subjects revealed impaired expression of heat shock proteins in the adipose tissue. Lipids Health Dis. 2014;13:106. PubMed DOI PMC

Lee KY, Kim SJ, Cha YS, So JR, Park JS, Kang KS, et al. Effect of exercise on hepatic gene expression in an obese mouse model using cDNA microarrays. Obesity. 2006;14:1294–302. PubMed DOI

Chiang JL, Kirkman MS, Laffel LMB, Peters AL. Type 1 Diabetes Sourcebook A. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diab Care. 2014;37:2034–54. PubMed DOI PMC

Zhang PH, Chen ZW, Lv D, Xu YY, Gu WL, Zhang XH, et al. Increased risk of cancer in patients with type 2 diabetes mellitus: a retrospective cohort study in China. BMC Public Health. 2012;12:1–6. PubMed DOI PMC

Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diab Endocrinol. 2018;6:69–80. PubMed DOI

Reinehr T, Wabitsch M. Type 2 diabetes mellitus in children and adolescents. Oxford: Blackwell Science Publ; 2005. pp. 21–40.

Campbell-Thompson M, Rodriguez-Calvo T, Battaglia M. Abnormalities of the exocrine pancreas in type 1 diabetes. Curr Diab Rep. 2015;15:79. PubMed DOI PMC

Mao YX, Tao M, Jia XY, Xu H, Chen K, Tang HW, et al. Effect of diabetes mellitus on survival in patients with pancreatic cancer: a systematic review and meta-analysis. Sci Rep. 2015;5:1–11. PubMed DOI PMC

Zou X, Hu M, Huang X, Zhou L, Li M, Chen J, et al. Rare variant in metallothionein 1E increases the risk of type 2 diabetes in a Chinese population. Diab Care. 2023;46:2249–57. PubMed DOI

Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diab-Metab Res Rev. 2001;17:189–212. PubMed DOI

Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J. The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos Univ Med J. 2012;12:5–18. PubMed PMC

Maiese K, Chong ZZ, Shang YC. Mechanistic insights into diabetes mellitus and oxidative stress. Curr Med Chem. 2007;14:1729–38. PubMed DOI PMC

Slepchenko KG, Chen S, Counts GP, Corbin KL, Colvin RA, Nunemaker CS. Synchrotron fluorescence imaging of individual mouse beta-cells reveals changes in zinc, calcium, and iron in a model of low-grade inflammation. Metallomics. 2021;13:1–10. PubMed DOI PMC

Wang K, Dai XZ, He JH, Yan XQ, Yang CK, Fan X, et al. Endothelial overexpression of metallothionein prevents diabetes-induced impairment in ischemia angiogenesis through preservation of HIF-1 alpha/SDF-1/VEGF signaling in endothelial progenitor cells. Diabetes. 2020;69:1779–92. PubMed DOI PMC

Ruttkay-Nedecky B, Nejdl L, Gumulec J, Zitka O, Masarik M, Eckschlager T, et al. The role of metallothionein in oxidative stress. Int J Mol Sci. 2013;14:6044–66. PubMed DOI PMC

Wei W, Liu QJ, Tan Y, Liu LC, Li XK, Cai L. Oxidative stress, diabetes and diabetic complications. Hemoglobin. 2009;33:370–7. PubMed DOI

Bensellam M, Laybutt DR, Jonas JC. Emerging roles of metallothioneins in beta cell pathophysiology: beyond and above metal homeostasis and antioxidant response. Biology. 2021;10:1–21. PubMed DOI PMC

Raudenska M, Gumulec J, Podlaha O, Sztalmachova M, Babula P, Eckschlager T, et al. Metallothionein polymorphisms in pathological processes. Metallomics. 2014;6:55–68. PubMed DOI

MacKenzie S, Bergdahl A. Zinc homeostasis in diabetes mellitus and vascular complications. Biomedicines. 2022;10:1–14. PubMed DOI PMC

Taylor CG. Zinc, the pancreas, and diabetes: insights from rodent studies and future directions. Biometals. 2005;18:305–12. PubMed DOI

Tallman DL, Taylor CG. Potential interactions of zinc in the neuroendocrine-endocrine disturbances of diabetes mellitus type 2. Can J Physiol Pharm. 1999;77:919–33. PubMed DOI

Mondragon P, Bergdahl A. Metallothionein expression in slow- vs. fast-twitch muscle fibers following 4 weeks of streptozotocin-induced type 1 diabetes. FACETS. 2018;3:315–25. DOI

Chen ML, Failla ML. Metallothionein metabolism in the liver and kidney of the streptozotocin-diabetic rat. Comp Biochem Physiol B Biochem Mol Biol. 1988;90:439–45. PubMed DOI

Coyle P, Philcox JC, Carey LC, Rofe AM. Metallothionein: the multipurpose protein. Cell Mol Life Sci. 2002;59:627–47. PubMed DOI PMC

Yang YP, Cherian MG. Protective effects of metallothionein on streptozotocin-induced diabetes in rats. Life Sci. 1994;55:43–51. PubMed DOI

Sato M, Kawakami T, Kondoh M, Takiguchi M, Kadota Y, Himeno S, et al. Development of high-fat-diet-induced obesity in female metallothionein-null mice. FASEB J. 2010;24:2375–84. PubMed DOI

Haynes V, Connor T, Tchernof A, Vidal H, Dubois S. Metallothionein 2a gene expression is increased in subcutaneous adipose tissue of type 2 diabetic patients. Mol Genet Metab. 2013;108:90–4. PubMed DOI

Tachibana H, Ogawa D, Sogawa N, Asanuma M, Miyazaki I, Terami N, et al. Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-induced diabetic mice. Am J Physiol Ren Physiol. 2014;306:105–15. PubMed DOI

Bensellam M, Shi Y-C, Chan JY, Laybutt DR, Chae H, Abou-Samra M, et al. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans. Diabetologia. 2019;62:2273–86. PubMed DOI

Ogawa D, Asanuma M, Miyazaki I, Tachibana H, Wada J, Sogawa N, et al. High glucose increases metallothionein expression in renal proximal tubular epithelial cells. Exp Diab Res. 2011;2011:534872. PubMed DOI PMC

Lu Y, Zhang YX, Lou Y, Cui WP, Miao LN. Sulforaphane suppresses obesity-related glomerulopathy-induced damage by enhancing autophagy via Nrf2. Life Sci. 2020;258:1–7. PubMed

Heger Z, Rodrigo MAM, Krizkova S, Ruttkay-Nedecky B, Zalewska M, del Pozo EMP, et al. Metallothionein as a scavenger of free radicals - new cardioprotective therapeutic agent or initiator of tumor chemoresistance?. Curr Drug Targets. 2016;17:1438–51. PubMed DOI

Cong WT, Zhao T, Zhu ZX, Huang BB, Ma WD, Wang YH, et al. Metallothionein prevents cardiac pathological changes in diabetes by modulating nitration and inactivation of cardiac ATP synthase. J Nutr Biochem. 2014;25:463–74. PubMed DOI

Zhou SS, Yin X, Zheng Y, Miao X, Feng WK, Cai J, et al. Metallothionein prevents intermittent hypoxia-induced cardiac endoplasmic reticulum stress and cell death likely via activation of Akt signaling pathway in mice. Toxicol Lett. 2014;227:113–23. PubMed DOI

Byrne NJ, Rajasekaran NS, Abel ED, Bugger H. Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy. Free Radic Biol Med. 2021;169:317–42. PubMed DOI PMC

Aroor AR, Mandavia CH, Sowers JR. Insulin resistance and heart failure: molecular mechanisms. Heart Fail Clin. 2012;8:609–17. PubMed DOI PMC

James PT, Rigby N, Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil. 2004;11:3–8. PubMed DOI

Sharma AM, Chetty VT. Obesity, hypertension and insulin resistance. Acta Diabetol. 2005;42:3–8. PubMed DOI

Hu LJ, Qiu C, Wang XS, Xu M, Shao XL, Wang YT. The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based F-18-FDG PET/CT study. BMC Cardiovasc Disord. 2018;18:1–8. PubMed DOI PMC

Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother. 2005;59:365–73. PubMed DOI

Wang J, Song Y, Elsherif L, Song Z, Zhou G, Prabhu Sumanth D, et al. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Circulation. 2006;113:544–54. PubMed DOI

Huang S, Wang JQ, Men HB, Tan Y, Lin Q, Gozal E, et al. Cardiac metallothionein overexpression rescues diabetic cardiomyopathy in Akt2-knockout mice. J Cell Mol Med. 2021;25:6828–40. PubMed DOI PMC

Song Y, Wang JX, Li Y, Du YB, Arteel GE, Saari JT, et al. Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury. Am J Pathol. 2005;167:17–26. PubMed DOI PMC

Giacconi R, Bonfigli AR, Testa R, Sirolla C, Cipriano C, Marra M, et al. +647 A/C and +1245 MT1A polymorphisms of diabetes mellitus and cardiovascular in the susceptibility complications. Mol Genet Metab. 2008;94:98–104. PubMed DOI

Kumar V, Singh J, Bala K, Singh J. Association of metallothionein 1A gene polymorphisms at rs11640851 and rs8052394 with risk of type 2 diabetes mellitus in Indian population. Meta Gene. 2021;28:1–5. DOI

Kozarova R, Postadzhiyan A, Apostolova MD. Association of+1245 A/G MT1A and-209 A/G MT2A polymorphysms with coronary artery disease and diabetes mellitus in Bulgarian cohort. Biotechnol Biotechnol Equip. 2012;26:100–6. DOI

Cai L. Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy. Free Radic Biol Med. 2006;41:851–61. PubMed DOI

Liang QR, Carlson EC, Donthi RV, Kralik PM, Shen X, Epstein PN. Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes. 2002;51:174–81. PubMed DOI

Sun WX, Miao X, Zhou SS, Zhang L, Epstein PN, Mellen N, et al. Zinc rescue of Akt2 gene deletion-linked murine cardiac dysfunction and pathological changes is metallothionein-dependent. J Mol Cell Cardiol. 2014;74:88–97. PubMed DOI

Xu J, Wang G, Wang Y, Liu Q, Xu W, Tan Y, et al. Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection. J Cell Mol Med. 2009;13:1499–512. PubMed DOI PMC

Zhou GH, Li XK, Hein DW, Xiang XL, Marshall JP, Prabhu SD, et al. Metallothionein suppresses angiotensin II-Induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart. J Am Coll Cardiol. 2008;52:655–66. PubMed DOI

Xue WL, Liu Y, Zhao J, Cai L, Li X, Feng W. Activation of HIF-1 by metallothionein contributes to cardiac protection in the diabetic heart. Am J Physiol Heart Circ Physiol. 2012;302:2528–35. PubMed DOI

Dong F, Li Q, Sreejayan N, Nunn JM, Ren J. Metallothionein prevents high-fat diet–induced cardiac contractile dysfunction. Diabetes. 2007;56:1–12. PubMed DOI

Yu L, Liu Y, Jin Y, Liu T, Wang W, Lu X, et al. Zinc supplementation prevented type 2 diabetes-induced liver injury mediated by the Nrf2-MT antioxidative pathway. J Diab Res. 2021;2021:1–14. PubMed DOI PMC

Wang YH, Feng WK, Xue WL, Tan Y, Hein DW, Li XK, et al. Inactivation of GSK-3 beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling. Diabetes. 2009;58:1391–402. PubMed DOI PMC

Van Hove I, De Groef L, Boeckx B, Modave E, Hu TT, Beets K, et al. Single-cell transcriptome analysis of the Akimba mouse retina reveals cell-type-specific insights into the pathobiology of diabetic retinopathy. Diabetologia. 2020;63:2235–48. PubMed DOI

Xue M, Joo YA, Li ST, Niu C, Chen G, Yi XC, et al. Metallothionein Protects the Heart Against Myocardial Infarction via the mTORC2/FoxO3a/Bim Pathway. Antioxid Redox Signal. 2019;31:403–19. PubMed DOI

Ohly P, Dohle C, Abel J, Seissler J, Gleichmann H. Zinc sulphate induces metallothionein in pancreatic islets of mice and protects against diabetes induced by multiple low doses of streptozotocin. Diabetologia. 2000;43:1020–30. PubMed DOI

Ho E, Quan N, Tsai YH, Lai W, Bray TM. Dietary zinc supplementation inhibits NFkappaB activation and protects against chemically induced diabetes in CD1 mice. Exp Biol Med. 2001;226:103–11. PubMed DOI

Chen H, Carlson EC, Pellet L, Moritz JT, Epstein PN. Overexpression of metallothionein in pancreatic beta-cells reduces streptozotocin-induced DNA damage and diabetes. Diabetes. 2001;50:2040–6. PubMed DOI

Costarelli L, Muti E, Malavolta M, Cipriano C, Giacconi R, Tesei S, et al. Distinctive modulation of inflammatory and metabolic parameters in relation to zinc nutritional status in adult overweight/obese subjects. J Nutritional Biochem. 2010;21:432–7. PubMed DOI

Mota Martins L, Soares de Oliveira AR, Clímaco Cruz KJ, Borges de Araújo CG, de Oliveira FE, Santos de Sousa G, et al. Influence of cortisol on zinc metabolism in morbidly obese women. Nutr Hosp. 2014;29:57–63. PubMed

Sylaja PN, Srivastava MVP, Shah S, Bhatia R, Khurana D, Sharma A, et al. The SARS-CoV-2/COVID-19 pandemic and challenges in stroke care in India. Ann N Y Acad Sci. 2020;1473:3–10. PubMed DOI PMC

Simon Abadia C. COVID-19, a graphic account. Emergencias. 2020;32:206–9. PubMed

Mahase E. Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction. BMJ. 2020;368:1. PubMed

Muralidar S, Ambi SV, Sekaran S, Krishnan UM. The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie. 2020;179:85–100. PubMed DOI PMC

Di Stadio A, Ricci G, Greco A, de Vincentiis M, Ralli M. Mortality rate and gender differences in COVID-19 patients dying in Italy: a comparison with other countries. Eur Rev Med Pharm Sci. 2020;24:4066–7. PubMed

Zakka K, Chidambaram S, Mansour S, Mahawar K, Salminen P, Almino R, et al. SARS-CoV-2 and obesity: “CoVesity”—a pandemic within a pandemic. Obes Surg. 2021;31:1745–54. PubMed DOI PMC

Lisco G, De Tullio A, Giagulli VA, Guastamacchia E, De Pergola G, Triggiani V. Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review. Endocrine. 2020;70:441–53. PubMed DOI PMC

Bae S, Kim SR, Kim M-N, Shim WJ, Park S-M. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart. 2021;107:1–8. PubMed DOI

Lim S, Bae JH, Kwon H-S, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17:11–30. PubMed DOI PMC

McGurnaghan SJ, Weir A, Bishop J, Kennedy S, Blackbourn LAK, McAllister DA, et al. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diab Endocrinol. 2021;9:82–93. PubMed DOI PMC

Unnikrishnan R, Misra A. Diabetes and COVID19: a bidirectional relationship. Nutr Diab. 2021;11:1–5. PubMed DOI PMC

Al-Sabah S, Al-Haddad M, Al-Youha S, Jamal M, Almazeedi S. COVID-19: Impact of obesity and diabetes on disease severity. Clin Obes. 2020;10:1–6. PubMed DOI PMC

Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum?. Indian J Endocrinol Metab. 2016;20:546–51. PubMed DOI PMC

Carey IM, Critchley JA, DeWilde S, Harris T, Hosking FJ, Cook DG. Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diab Care. 2018;41:1–9. PubMed DOI

Pelle MC, Zaffina I, Provenzano M, Moirano G, Arturi F. COVID-19 and diabetes—two giants colliding: From pathophysiology to management. Front Endocrinol. 2022;13:1–13. PubMed DOI PMC

Pfortmueller CA, Spinetti T, Urman RD, Luedi MM, Schefold JC. COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment – a narrative review. Best Pract Res Clin Anaesthesiol. 2021;35:351–68. PubMed PMC

Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diab Endocrinol. 2022;10:311–21. PubMed DOI PMC

van der Heide V, Jangra S, Cohen P, Rathnasinghe R, Aslam S, Aydillo T, et al. Limited extent and consequences of pancreatic SARS-CoV-2 infection. Cell Rep. 2022;38:1–28. PubMed PMC

Boudreault F, Pinilla-Vera M, Englert JA, Kho AT, Isabelle C, Arciniegas AJ, et al. Zinc deficiency primes the lung for ventilator-induced injury. JCI Insight. 2017;2:1–15. PubMed DOI PMC

Jarosz M, Olbert M, Wyszogrodzka G, Młyniec K, Librowski T. Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling. Inflammopharmacology. 2017;25:11–24. PubMed DOI PMC

Rahman MT, Karim MM. Metallothionein: a Potential Link in the Regulation of Zinc in Nutritional Immunity. Biol Trace Elem Res. 2018;182:1–13. PubMed DOI

Subramanian Vignesh K, Deepe GS Jr. Metallothioneins: Emerging Modulators in Immunity and Infection. Int J Obes. 2017;18:1–25. PubMed PMC

Sethuram R, Bai D, Abu-Soud HM. Potential Role of Zinc in the COVID-19 Disease Process and its Probable Impact on Reproduction. Reprod Sci. 2022;29:1–6. PubMed DOI PMC

Su YP, Chen D, Yuan D, Lausted C, Choi J, Dai CZL, et al. Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19. Cell. 2020;183:1479. PubMed DOI PMC

Herrera-Quintana L, Vázquez-Lorente H, Gamarra-Morales Y, Molina-López J, Planells E. Evolution of Status of Trace Elements and Metallothioneins in Patients with COVID-19: Relationship with Clinical, Biochemical, and Inflammatory Parameters. Metabolites. 2023;13. PubMed PMC

Rahmani-Kukia N, Abbasi A, Pakravan N, Hassan ZM. Measurement of oxidized albumin: an opportunity for diagnoses or treatment of COVID-19. Bioorganic Chem. 2020;105:104429. PubMed PMC

Abouhashem AS, Singh K, Azzazy HME, Sen CK. Is low alveolar type II cell SOD3 in the lungs of elderly linked to the observed severity of COVID-19?. Antioxid Redox Signal. 2020;33:59–65. PubMed DOI PMC

Cabrera AJR. Zinc, aging, and immunosenescence: an overview. Pathobiol Aging Age Relat Dis. 2015;5:25592. PubMed DOI PMC

Uwitonze AM, Ojeh N, Murererehe J, Atfi A, Razzaque MS. Zinc adequacy is essential for the maintenance of optimal oral health. Nutrients. 2020;12:1–14. PubMed DOI PMC

Tsuchiya H. Gustatory and saliva secretory dysfunctions in COVID-19 patients with zinc deficiency. Life. 2022;12:1–26. PubMed DOI PMC

Singh S, Diwaker A, Singh BP, Singh RK. Nutritional immunity, zinc sufficiency, and COVID-19 mortality in socially similar European populations. Front Immunol. 2021;12:1–10. PubMed DOI PMC

Livanos AE, Jha D, Cossarini F, Gonzalez-Reiche AS, Tokuyama M, Aydillo T, et al. Intestinal host response to SARS-CoV-2 infection and COVID-19 outcomes in patients with gastrointestinal symptoms. Gastroenterology. 2021;160:2435–50. PubMed DOI PMC

Sumaily KM. The roles and pathogenesis mechanisms of a number of micronutrients in the prevention and/or treatment of chronic hepatitis, COVID-19 and type-2 diabetes mellitus. Nutrients. 2022;14:2632. PubMed PMC

Vijay J, Gauthier MF, Biswell RL, Louiselle DA, Johnston JJ, Cheung WA, et al. Single-cell analysis of human adipose tissue identifies depot- and disease-specific cell types. Nat Metab. 2020;2:97–109. PubMed DOI PMC

Puerta M, Abelenda M, Rocha M, Trayhurn P. Effect of acute cold exposure on the expression of the adiponectin, resistin and leptin genes in rat white and brown adipose tissues. Horm Metab Res. 2002;34:629–34. PubMed DOI

Gomez-Santos C, Hernandez-Morante JJ, Margareto J, Larrarte E, Formiguera X, Martinez CM, et al. Profile of adipose tissue gene expression in premenopausal and postmenopausal women: site-specific differences. Menopause. 2011;18:675–84. PubMed DOI